INTRODUCTION
Wohlfahrtiimonas (W.) chitiniclastica was first described by Tόth et al. in 2008. The strain was isolated from a homogenate of larvae of the fly Wohlfahrtia (Woh.) magnifica [Reference Toth1]. These flies are ectoparasites, which are fully dependent on the host to complete their life cycle (obligate parasites). They are an important cause of myiasis in both animals and humans [Reference Robbins and Khachemoune2]. For the bacterial isolate Tόth and co-workers proposed the name Wohlfahrtiimonas gen.nov. and defined W. chitiniclastica as the first species [Reference Toth1]. In 2014 Lee et al. described an additional species named W. larvae [Reference Lee3].
W. chitiniclastica are Gram-negative, strictly aerobic and non-motile rods, which lack the ability to form endospores [Reference Toth1]. The optimal growth temperature is between 28 °C and 37 °C [Reference Toth1]. Both catalase and oxidase reaction are positive while tests for urease, indole and H2S are negative [Reference Toth1]. A strong chitinase activity is an important characteristic. This enzyme may play a role in the metamorphosis of the fly suggesting a symbiotic relationship between the insect and the bacterium [Reference Toth1, Reference Rebaudet4]. Additionally, there is a close relationship between W. chitiniclastica and Ignatzschineria larvae (bacteria which also express chitinase and are linked to larvae as well) [Reference Toth5]. Up to now a few case reports have been published suggesting that W. chitiniclastica itself is pathogenic for humans and may be the cause of severe diseases such as bloodstream infections or osteomyelitis [Reference Rebaudet4, Reference Almuzara6, Reference Koljalg7]. Bacteria are thought to be transmitted through fly larvae in traumatic skin lesions and/or mucosal surfaces of the host [Reference Robbins and Khachemoune2, Reference Thaiwong8]. In this review, we summarize the current reports on human infections caused by W. chitiniclastica. All available literature is included and furthermore, we present four of our own cases of human W. chitiniclastica infections from patients treated at Dresden University Hospital between 2013 and 2015.
SEARCH STRATEGY
Search
A literature search in PubMed, using the following key words, was performed: ‘Wohlfahrtiimonas chitiniclastica’, ‘Wohlfahrtiimonas chitiniclastica AND infection’, ‘Wohlfahrtiimonas chitiniclastica AND human’, ‘myiasis AND Wohlfahrtia magnifica’. All studies published since the first description of W. chitiniclastica in 2008 were included up to August 2016. All references cited in the relevant articles were evaluated according to their relevance for the topic of this review.
Selection
All case reports describing human infections caused or associated with W. chitiniclastica were included together with the first description of the bacterial strain. Furthermore, relevant articles about Woh. magnifica and myiasis were selected.
Inclusion of own data
In addition to the results obtained from the literature search we included data from four patients treated at the Dresden University Hospital between 2013 and 2015. In all these cases W. chitiniclastica was confirmed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS; Bruker Daltonics, Germany) and sequencing of the 16S rRNA gene. It transpired that the VITEK 2 system (bioMérieux, Germany), also used in our laboratory, constantly misidentified the investigated strains, assigning different and false species names to them.
RESULTS
Cases
Eight case reports dealing with W. chitiniclastica infections in humans were identified by PubMed search using the search term ‘Wohlfahrtiimonas chitiniclastica AND human’. One of the reports, however, describes a fatal outcome of a W. chitiniclastica infection in a deer [Reference Thaiwong8] in the USA, and another publication reports on a dolphin suffering from endocarditis [Reference Josue9]. Additionally, in a recently published case report hoof cellulitis of a cow is presented [Reference Qi10]. These three reports on veterinary cases did not meet our search criteria since we wanted to include only human infections. In contrast, the search criterion ‘Wohlfahrtiimonas chitiniclastica AND infections’ revealed only seven cases including the above-mentioned two zoonotic cases. Using ‘Wohlfahrtiimonas chitiniclastica’ as a search criterion alone, produced 12 results, including the initial description by Tóth et al. [Reference Toth1]. Furthermore, another publication about the pathogen's occurrence in the insect species Hermetia illucens [Reference Lee3] and a report on a whole genome sequence of a W. chitiniclastica strain [Reference Cao11] appeared. To date, seven case reports and in total eight cases have been published on W. chitiniclastica infections in humans (case numbers: 1 [Reference Rebaudet4], 2 [Reference Almuzara6], 3 [Reference Campisi, Mahobia and Clayton12], 4 [Reference Koljalg7], 5 [Reference Suryalatha, John and Thomas13], 6 [Reference de Dios14], 7, 8 [Reference Nogi, Bankowski and Pien15]). Additionally, we report on the outcome of four patients treated at Dresden University Hospital during the last three years (cases 9–12).
Patients’ characteristics
Age and gender
Five patients were female (cases 1, 3, 5, 8, 12) and seven were male (cases 2, 4, 5, 6, 8, 10, 11). The medium age was 63·75 years with a range from 26 years (case 6) to 82 years (case 3). These data are summarized in Table 1.
NP, Not provided.
Social history/living conditions
Information about the patient`s social situation and living conditions were not provided for four of the 12 cases (cases 3, 4, 6, 9). Five patients were reported to be homeless (cases 1, 2, 5, 8, 10), one patient (case 11) was living alone under difficult social conditions (not further specified), one patient (case 9) lived under normal social conditions (not further specified) and one patient (case 11) lived under poor hygienic conditions (not further specified). Alcohol abuse was reported in four of the 12 cases (cases 1, 2, 5, 10). Two patients were smokers (cases 2 and 5). No information was given in six cases (cases 3, 4, 6–8, 12). These data are summarized in Table 1.
Underlying diseases
No information about a basic disease was provided for three patients (cases 1, 4, 10). Five patients (cases 2, 3, 9, 11, 12) had circulatory diseases such as chronic venous insufficiency, ischaemic heart disease, arteriopathy including coronary artery disease or arterial hypertension. Two patients (cases 6 and 11) were reported to be obese and two patients (cases 5 and 9) were known to suffer from diabetes. Two patients (cases 3 and 9) additionally had renal dysfunction. One patient (case 7) was reported with a stroke and one patient (case 8) with a hemiparesis due to a ruptured cerebral aneurysm. A comprehensive summary is given in Table 1.
Infections reported in association with W. chitiniclastica
In four cases bloodstream infections caused by W. chitiniclastica were reported (cases 1–3, 7). In case 7 E. coli was detected in addition to W. chitiniclastica. One patient (case 4) was admitted to hospital due to a necrotizing skin infection. Two patients (cases 5 and 6) suffered from cellulitis. Case 5 additionally suffered from a deep ulcer which progressed to osteomyelitis. Five patients (cases 8–12) suffered from infected ulcers. These data are summarized in Table 2.
NP, Not provided; NA, not administered.
Monomicrobial vs. polymicrobial infection
In four cases W. chitiniclastica was the only bacterium which could be identified and in eight cases at least one additional bacterium could be identified or W. chitiniclastica was part of a polymicrobial spectrum. In four cases, W. chitiniclastica was isolated from blood cultures, in one case the samples were taken during surgery and seven samples were taken from skin-related diseases (e.g. ulcers). In cases 1, 2 and 5 W. chitiniclastica was the only bacterium isolated and in case 3 the organism was isolated from primary blood cultures taken upon the patient's admission to hospital. However, further cultures grew in this patient: Proteus mirabilis, Providencia rettgeri and Staphylococcus aureus. Eight cases (4, 6–12) suffered from a polymicrobial infection where W. chitiniclastica was isolated together with other sepsis-causing pathogens. In case 4 Myroides odoratimimus was additionally detected, in case 6 P. vulgaris, Klebsiella pneumoniae, Acinetobacter lwoffii and S. aureus were identified, in case 7 both W. chitiniclastica and Escherichia coli were detected in the blood culture, in case 8 W. chitiniclastica was detected together with S. aureus, Aeromonas spp., Streptococcus simulans and Bacteroides fragilis. In case 9, E. coli and bacteria of the anaerobic skin flora (without further characterization) were detected. Blood cultures of case 10 grew skin flora together with P. mirabilis. In case 11 normal aerobic skin flora, Proteus vulgaris, S. aureus, Morganella morganii, Serratia marcescens and W. chitiniclastica were detected, and in case 12 normal aerobic skin flora, P. mirabilis, Pseudomonas aeruginosa and Providencia stuartii were identified (Table 2).
Antibiotic treatment and patient outcome
Nine of 12 patients received antibiotic treatment, mostly β-lactams (e.g. penicillins and cephalosporins) and quinolones. Treatment strategy was changed in five patients (second-line antibiotics). Two out of 12 patients died. Case 1 was effectively treated with 2 g/d ceftriaxone. Case 2 received a combination of 400 mg ciprofloxacin every 12 h and 1·5 g ampicillin/sulbactam every 6 h. For case 3, 750 mg cefuroxime and 500 mg metronidazole were administered 3 times a day and 500 mg clarithromycin twice a day. The therapy was changed to 500 mg flucloxacillin four times a day. The patient did not survive. Case 4 received amoxicillin/clavulanate for 8 days and the outcome was positive. There is no information about antibiotic treatment for case 5. Case 6 received a 10-day course of cefpodoxime. Case 7 was given piperacillin/tazobactam, clindamycin and vancomycin. This patient died 1 day after admission. Case 8 initially received ceftaroline which was changed later to meropenem. For case 9 a 4-day antibiotic treatment with 500 mg levofloxacin twice a day and 600 mg clindamycin three times a day was performed. Cases 10–12 did not receive any antibiotic treatment. These data are summarized in Table 2.
Geographical distribution and epidemiological aspects
Cases 1 (Marseille, France), 3 (Guilford, UK), 4 (Tartu, Estonia), 9–12 (Dresden, Germany) were reported from European countries. Case 2 was reported from Argentina (Buenos Aires) and case 5 from India (Trivandrum). Three cases were reported form North America (cases 6–8). Table 1 summarizes the geographical distribution of W. chitiniclastica isolates presented in this review.
Methods of identification
MALDI-TOF MS
W. chitiniclastica was successfully identified by MALDI-TOF MS [Reference Schröttner16] in cases 3 (scores 2·264 and 2·200), 4 (scores 2·350, 2·389 and 2·259), 5 (score not provided), 6 (scores 2·253, 2·296 and 2·229), 9 (score 2·262), 10 (2·441), 11 (score 2·019) and 12 (score 2·396). Figure 1 shows the spectra of the W. chitiniclastica-type strain (DSM 18708) and of the four strains isolated at our hospital (DSM 100375, DSM 100374, DSM 100676, DSM 100917). The MALDI-TOF MS scores of all strains are summarized in Table 2. Scores show the reliability of the species identification. Scores above 2·300 represent a highly probable species identification, a score between 2·000 and 2·300 indicates a secure species identification, a score between 1·700 and 2·000 represents a probable species identification and a score below 1·700 is not reliable [Reference Schröttner16].
16S rDNA sequencing
W. chitiniclastica was correctly identified by 16S rRNA gene sequencing in cases 1 (homology data not provided), 2 (99% homology), 3 (homology data not provided), 4 (99% homology), 5 (homology data not provided), 6 (homology data not provided), 7 (100% homology), 8 (100% homology), 9 (100% homology), 10 (100% homology), 11 (100% homology) and 12 (100% homology). The data are summarized in Table 2.
Biochemical testing using VITEK 2
In cases 1 and 5 phenotypic analysis failed to identify the bacteria. However, the tests applied were not further described. In case 2 API 20 NE identified the strain as Brevundimonas diminuta or Oligella urethralis with a low probability of 88·5%. In case 4 the identification utilizing VITEK 2 revealed Comamonas testosteroni with a probability of 99%. However, 16S rDNA sequencing showed a homology to C. testosterone-type strain DSM 50244 with only 82%. In the following three cases, using VITEK 2, W. chitiniclastica was misidentified as A. lwoffii, i.e. cases 6 (probability 96%), 9 (probability 99%) and 10 (probability 96%). The biochemical reactions detected by VITEK 2, using the GN card, are presented in Supplementary Table S1. The substrates on the GN card are listed in table 7 of the Encyclopedia of Rapid Microbiological Methods [Reference Pincus and Miller17]. In addition to the W. chitiniclastica-type strain (DSM 18708), results from the four isolates collected at Dresden University Hospital (DSM 100374, DSM 100375, DSM 100676, DSM 100917) are included.
Antimicrobial susceptibility testing
Among the group of β-lactam antibiotics, W. chitiniclastica was susceptible to penicillins, cephalosporins and carbapenems (cases 1, 2, 4–12), to quinolones (cases 1, 2, 5–12), aminoglycosides (cases 1, 2, 4–12), trimethoprim/sulfamethoxazole (cases 1, 2, 4–10), colistin (case 4) or tetracycline (cases 2, 7, 8). No resistance data were provided for case 3. Testing was performed using E-test strips (BESTBION, Germany) according to the EUCAST guidelines for 2016.
In agreement with published data the type strain DSM 18708 and our isolates were also susceptible to β-lactam antibiotics, to quinolones and to tigecycline. The minimum inhibitory concentration (MIC) values are given in Table 3. Testing was performed according the guidelines using non-species-related breakpoints of the European Committee on Antimicrobial Susceptibility Testing (EUCAST; http://www.eucast.org/). Additionally, we tested our strains against trimethoprim/sulfamethoxazole, fosfomycin, colistin, gentamicin, amikacin, erythromycin and azithromycin (Table 3). However, EUCAST non-species-related breakpoints are not available for these antibiotics. MIC values ranged from 0·032 μg/ml to 4 µg/ml, except for fosfomycin, which revealed MIC values >1024 µg/ml in all isolates presented in Table 3.
MIC, Minimum inhibitory concentration; S, susceptible; IE, insufficient evidence; EUCAST, European Committee on Antimicrobial Susceptibility Testing [breakpoint tables for interpretation of MICs and zone diameters, version 6.0, 2016 (http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_6.0_Breakpoint_table.pdf)].
DISCUSSION
W. chitiniclastica was first isolated from samples of the obligate parasitic fly Woh. magnifica in 2008 [Reference Toth1, Reference Robbins and Khachemoune2, Reference Cao11]. The sequenced W. chitiniclastica strain SH04 has a genome size of 2·12 Mb, with an average G/C content of 43·48%. It contains 2006 open reading frames [Reference Cao11]. Further investigations revealed a high similarity to I. larvae, another bacterial species which is also commonly found in flies [Reference Toth1, Reference Toth5]. The transmission of these bacteria therefore seems to be closely linked to these insects. Female flies of the species Woh. magnifica deposit eggs in traumatic skin lesions or on mucosal surfaces of the affected host [Reference Ruiz-Martinez18]. The developed larvae feed within the tissue leading to significant destruction which may even result in a fatal outcome [Reference Goddard19]. After 5–7 days the larvae fall to the ground and pupate. At this stage of the insect's life cycle the enzyme chitinase may play an important role by supporting the insects in their pupation [Reference Toth20].
In addition to the close link of W. chitiniclastica to certain flies, the bacteria have recently been detected in arsenic-affected soils from Bangladesh [Reference Sanyal21]. Furthermore, Matos and co-workers found W. chitiniclastica in multiple samples of chicken meat purchased in Brazilian supermarkets [Reference Matos22]. The occurrence of this bacterium indicates poor sanitary conditions and is contrary to good manufacturing practice [Reference Matos22]. Because the fly Woh. magnifica does not occur in South America another route of infection via C. megacephala as depositor of W. chitiniclastica was suggested.
To date, four well documented cases (cases 1–4) of invasive/bloodstream infections caused by W. chitiniclastica have been reported [Reference Rebaudet4, Reference Almuzara6, Reference Koljalg7, Reference Campisi, Mahobia and Clayton12]. It is probable that the bacteria are transmitted to the tissue of the host by larvae and may reach the bloodstream while being distributed in the tissue. In these case descriptions, W. chitiniclastica was the only bacterium isolated. One patient died due to septic shock caused by W. chitiniclastica [Reference Almuzara6].
However, in cases 5, 6 and 9–12 W. chitiniclastica was part of a polymicrobial spectrum and therefore it is impossible to clarify if W. chitiniclastica was the sole cause of infection (see references in Table 2). Mouse infection experiments published recently by Qi et al. revealed W. chitiniclastica being pathogenic to mice only at large doses, i.e. 109–1010 colony-forming units per intraperitoneal injection [Reference Qi10]. In cases 7 and 8, published recently by Nogi et al., the authors report on two patients with soft tissue infection and sepsis [Reference Nogi, Bankowski and Pien15]. In both cases W. chitiniclastica was not the sole cause of the disease [Reference Nogi, Bankowski and Pien15]. In case 7 E. coli was additionally identified and in case 8 W. chitiniclastica was part of a large polymicrobial spectrum consisting of aerobic and anaerobic pathogens [Reference Nogi, Bankowski and Pien15].
W. chitiniclastica patients, their underlying diseases and cause of hospitalization are listed in Table 1. Most patients suffered from diseases affecting the skin such as ulcers (cases 9–11 [Reference Suryalatha, John and Thomas13–Reference Nogi, Bankowski and Pien15]), wounds (cases 7 and 8 [Reference Nogi, Bankowski and Pien15]), gangrene (cases 4 and 5 [Reference Koljalg7, Reference Suryalatha, John and Thomas13]) or cellulitis (case 5 [Reference Suryalatha, John and Thomas13]). Patients suffered also from impairments of the cardiovascular system such as occlusive arteriopathy (case 2 [Reference Almuzara6]), hypertension (cases 3 [Reference Campisi, Mahobia and Clayton12] and 11), different heart diseases (cases 3 [Reference Campisi, Mahobia and Clayton12], 9 and 11), chronic venous insufficiency (cases 9 and 11) or deep vein thrombosis (case 12). The two patients reported by Nogi et al. (cases 7 and 8) suffered from neurological disorders, stroke and ruptured cerebral aneurysm [Reference Nogi, Bankowski and Pien15]. Conditions leading to an increased probability of maggot infestation can be considered a risk factor for W. chitiniclastica infections. Cases 1, 2, 8 [Reference Rebaudet4, Reference Almuzara6, Reference Nogi, Bankowski and Pien15] and 10 were reported to be homeless, thus being at higher risk of being affected by myiasis. Case 3, who exhibited multiple maggots and insect larvae, was found unconscious in her garden after collapsing 72–96 h earlier [Reference Campisi, Mahobia and Clayton12]. Since many (especially vascular) diseases are typical for older patients it is not surprising that the mean age of W. chitiniclastica patients was found to be 63·75 years. Gender, however, does not seem to play a role.
The cases described here are reports from different parts of the world. At the time of writing the fly Woh. magnifica is found in continental Europe and the Middle East [Reference Robbins and Khachemoune2] but is unknown in the UK [Reference Rebaudet4, Reference Campisi, Mahobia and Clayton12], South America [Reference Almuzara6], North America [Reference de Dios14] and Asia [Reference Suryalatha, John and Thomas13]. However, it is likely that the bacteria can be transmitted by different insects. For instance, as described in case 3, the common green bottle fly Lucilia sericata was identified as source of a W. chitiniclastica infection [Reference Campisi, Mahobia and Clayton12]. Furthermore, W. chitiniclastica could be isolated from the flies Chrysomya megacephala and Musca domestica [Reference Koljalg7, Reference Gupta23].
Based on the current literature and our own experience biochemical approaches such as API (Analyical Profile Index, bioMérieux, Germany) or VITEK 2 (bioMérieux) to identify W. chitiniclastica lead to wrong and misleading results. The biochemical profiles, obtained by VITEK 2, of the four isolates from Dresden University Hospital and two type strains are given in Supplementary Table S1. Almuzara et al. used the API 20 NE system which resulted in B. diminuta or O. urethralis [Reference Almuzara6]. Analyses using the VITEK 2 system identified the bacterium as C. testosteroni with an excellent result (99% identitiy) or as A. lwoffii (96–99% identity) (cases 6–8) [Reference de Dios14, Reference Nogi, Bankowski and Pien15]. De Dios et al. compared the biochemical profiles of A. lwoffii and W. chitiniclastica using both VITEK 2 and API 20 NE. They revealed that both bacteria showed an identical profile except for oxidase activity (A. lwoffii is oxidase negative and W. chitiniclastica is oxidase positive) [Reference de Dios14]. 16S rRNA gene sequencing and MALDI-TOF MS, however, gave reproducible and reliable identification of W. chitiniclastica [Reference Koljalg7, Reference Campisi, Mahobia and Clayton12–Reference Nogi, Bankowski and Pien15]. We have described and compared both methods in detail recently [Reference Schröttner16]. MALDI-TOF MS, however, has the advantage of speed.
Antimicrobial susceptibility testing was performed in 11 out of the 12 cases and revealed that W. chitiniclastica is susceptible to β-lactam antibiotics, quinolones, aminoglycosides, colistin, trimethoprim/sulfamethoxazole and tetracyclin as reported in the literature [Reference Rebaudet4, Reference Almuzara6, Reference Koljalg7, Reference Suryalatha, John and Thomas13–Reference Nogi, Bankowski and Pien15] and measured in our isolates given in Table 3. According to our investigations the MIC value determined for fosfomycin is very high (Table 3). This observation is in accord with results from Matos and co-workers who also found MIC values of >32 µg/ml in the samples they investigated [Reference Matos22]. These results suggest that W. chitiniclastica is intrinsically resistant to fosfomycin. In the same way it can be assumed that W. chitiniclastica is (due to the low MIC values determined in vitro) susceptible to tigecycline (Table 3). Most patients received an antimicrobial treatment using β-lactam antibiotics with a combination of quinolones or aminoglycosides. All patients except two [Reference Almuzara6, Reference Nogi, Bankowski and Pien15] survived. The fatal outcomes, however, may be explained by these patients poor condition upon admission to the hospital. Additionally, for case 7, described by Nogi et al., it remains unclear if W. chitiniclastica or E. coli were responsible for the patient's septic condition [Reference Nogi, Bankowski and Pien15]. Table 3 shows the antimicrobial profiles measured for the W. chitiniclastica-type strain (DSM 18708) and the four isolates from our hospital (DSM 100374, DSM 100375, DSM 100676, DSM 100917).
In conclusion, W. chitiniclastica is a recently described bacterial pathogen whose appearance is linked to certain flies. These insects carry and distribute this bacterium to a host. Since biochemistry-based approaches fail to correctly identify this bacterium MALDI-TOF MS or 16S rRNA gene sequencing are required for confirmation. Since W. chitiniclastica is susceptible to a wide range of antibiotics, treatment with β-lactam antibiotics alone or combined with quinolones or aminoglycosides may successfully be administered. Due to the few data currently available, more epidemiological research and an awareness that this bacterium can cause serious infections is needed. For rapid, economic and reliable detection MALDI-TOF MS will be the right diagnostic tool [Reference Schröttner16].
SUPPLEMENTARY MATERIAL
For supplementary material accompanying this paper visit https://doi.org/10.1017/S0950268816003411.
ACKNOWLEDGEMENTS
The authors did not receive funding for this work. We thank Dr. Bärbel Fösel and PD Dr. Sabine Gronow for including our strains in the DSMZ Open collection.
DECLARATION OF INTEREST
None.